Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Carcinoma, Non-Small-Cell Lung
  • Drugs, Chinese Herbal
  • Lung Neoplasms
  • Plant Extracts
  • Taxoids

abstract

  • Jinfukang did not alter the pharmacokinetics of docetaxel nor appear to affect survival in this study.

publication date

  • May 7, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3746541

Digital Object Identifier (DOI)

  • 10.1007/s00280-009-1003-z

PubMed ID

  • 19421753

Additional Document Info

start page

  • 67

end page

  • 71

volume

  • 65

number

  • 1